PIAS1 Promotes Lymphomagenesis through MYC Upregulation

Cell Rep. 2016 Jun 7;15(10):2266-2278. doi: 10.1016/j.celrep.2016.05.015. Epub 2016 May 26.

Abstract

The MYC proto-oncogene is a transcription factor implicated in a broad range of cancers. MYC is regulated by several post-translational modifications including SUMOylation, but the functional impact of this post-translational modification is still unclear. Here, we report that the SUMO E3 ligase PIAS1 SUMOylates MYC. We demonstrate that PIAS1 promotes, in a SUMOylation-dependent manner, MYC phosphorylation at serine 62 and dephosphorylation at threonine 58. These events reduce the MYC turnover, leading to increased transcriptional activity. Furthermore, we find that MYC is SUMOylated in primary B cell lymphomas and that PIAS1 is required for the viability of MYC-dependent B cell lymphoma cells as well as several cancer cell lines of epithelial origin. Finally, Pias1-null mice display endothelial defects reminiscent of Myc-null mice. Taken together, these results indicate that PIAS1 is a positive regulator of MYC.

MeSH terms

  • Animals
  • Carcinogenesis / genetics
  • Carcinogenesis / pathology*
  • Cell Line
  • Cell Proliferation
  • Cell Survival
  • Gene Expression Regulation, Neoplastic*
  • Half-Life
  • Humans
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / pathology*
  • Mice
  • Phosphorylation
  • Phosphothreonine / metabolism
  • Protein Binding / genetics
  • Protein Inhibitors of Activated STAT / metabolism*
  • Proteolysis
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-myc / genetics*
  • Proto-Oncogene Proteins c-myc / metabolism
  • Sumoylation
  • Transcription, Genetic
  • Up-Regulation / genetics*

Substances

  • MAS1 protein, human
  • Protein Inhibitors of Activated STAT
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-myc
  • Phosphothreonine